Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Neperlan - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Neperlan

Approved

STANDARD

Neperlan

Drugmakers lab.Inc🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: da6e11fde4d9cbc7
Company: Drugmakers lab.Inc
Type: Standard

Approval Details

Approval Id: da6e11fde4d9cbc7
Drug Approval Philippines Name: Neperlan
Product Name: Neperlan
Registration Number: DRP-8613
Brand Name: Neperlan
Generic Name: Piroxicam
Dosage Form: Capsule
Dosage Strength: 20mg
Manufacturer: Drugmakers lab.Inc
Issuance Date: 31 March 2023
Expiry Date: 31 March 2028
Pharmacologic Category: Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

da6e11fde4d9cbc7

Type

Standard

Back to Philippines FDA Approvals